Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 04, 2020

SELL
$6.45 - $14.04 $397,565 - $865,397
-61,638 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$12.97 - $15.94 $799,444 - $982,509
61,638 New
61,638 $848,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Pathway Capital Management, LP Portfolio

Follow Pathway Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Capital Management, LP with notifications on news.